Overview

Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that human brown adipose tissue (BAT) can be activated using a β3-adrenergic receptor (AR) agonist. The efficacy of β3-AR agonist will be compared with cold exposure, which we have already shown can activate human BAT, as well as a placebo control.
Phase:
Phase 2
Details
Lead Sponsor:
Aaron Cypess
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Treatments:
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-3 Receptor Agonists
Mirabegron